Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X P Liu

Showing results (31-40 of 109) with videos related to

Pageof 11
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
In vivo toxicity and pharmacokinetic features of the janus kinase 3 inhibitor WHI-P131 [4-(4'hydroxyphenyl)-amino-6,7- dimethoxyquinazolineF M Uckun, O Ek, X P Liu, et al.
Biochemical and Biophysical Research Communications|January 7, 2000
A specific inhibitor of janus kinase-3 increases survival in a transgenic mouse model of amyotrophic lateral sclerosisV N Trieu, R Liu, X P Liu, et al.
American Journal of Therapeutics|April 17, 2001
In vivo pharmacokinetics and anti-anaphylactic activity of the novel mast cell inhibitor 4-(4'-hydroxylphenyl)-amino-6,7-dimethoxyquinazoline (WHI-P131)R Malavija, C L Chen, X P Liu, et al.
Journal De Mycologie Medicale|April 22, 2014
Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012X P Liu, S R Fan, Y T Peng, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|October 12, 2000
An inhibitor of Janus kinase 3:4-(4-hydroxyphenylamino)-6, 7-dimethoxyquinazolin-1-ium chloride methanol solvateE A Sudbeck, J D Jennissen, X P Liu, et al.
Environmental Pollution (Barking, Essex : 1987)|May 20, 2015
Characteristics of air pollutant dispersion around a high-rise buildingY Zhang, K C S Kwok, X-P Liu, et al.
Journal of Cardiovascular Pharmacology|February 15, 2000
Treatment of atherosclerosis in apolipoprotein E-deficient mice with 4-(3-Bromobenzoyl)-6,7-dimethoxyquinazoline (WHI-P164), a potent inhibitor of triglyceride synthesisV N Trieu, X P Liu, C L Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
4-(3'-Bromo-4'hydroxylphenyl)-amino-6,7-dimethoxyquinazoline: a novel quinazoline derivative with potent cytotoxic activity against human glioblastoma cellsR K Narla, X P Liu, D E Myers, et al.
Zhonghua Nei Ke Za Zhi|December 3, 2025
[The 515th case:dry mouth and dry eyes, parotid gland enlargement, pulmonary patchy shadows, muscular nodules]J Wang, X P Liu, Y Y Dong, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|June 9, 1999
Quantitative high-performance liquid chromatographic method for pharmacokinetic studies of the potent mast cell inhibitor 4-(4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline (WHI-P131)C L Chen, R Malaviya, H Chen, et al.
Pageof 11

Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 1999
In vivo toxicity and pharmacokinetic features of the janus kinase 3 inhibitor WHI-P131 [4-(4'hydroxyphenyl)-amino-6,7- dimethoxyquinazolineF M Uckun, O Ek, X P Liu, et al.
Biochemical and Biophysical Research Communications|January 7, 2000
A specific inhibitor of janus kinase-3 increases survival in a transgenic mouse model of amyotrophic lateral sclerosisV N Trieu, R Liu, X P Liu, et al.
American Journal of Therapeutics|April 17, 2001
In vivo pharmacokinetics and anti-anaphylactic activity of the novel mast cell inhibitor 4-(4'-hydroxylphenyl)-amino-6,7-dimethoxyquinazoline (WHI-P131)R Malavija, C L Chen, X P Liu, et al.
Journal De Mycologie Medicale|April 22, 2014
Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012X P Liu, S R Fan, Y T Peng, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|October 12, 2000
An inhibitor of Janus kinase 3:4-(4-hydroxyphenylamino)-6, 7-dimethoxyquinazolin-1-ium chloride methanol solvateE A Sudbeck, J D Jennissen, X P Liu, et al.
Environmental Pollution (Barking, Essex : 1987)|May 20, 2015
Characteristics of air pollutant dispersion around a high-rise buildingY Zhang, K C S Kwok, X-P Liu, et al.
Journal of Cardiovascular Pharmacology|February 15, 2000
Treatment of atherosclerosis in apolipoprotein E-deficient mice with 4-(3-Bromobenzoyl)-6,7-dimethoxyquinazoline (WHI-P164), a potent inhibitor of triglyceride synthesisV N Trieu, X P Liu, C L Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 1998
4-(3'-Bromo-4'hydroxylphenyl)-amino-6,7-dimethoxyquinazoline: a novel quinazoline derivative with potent cytotoxic activity against human glioblastoma cellsR K Narla, X P Liu, D E Myers, et al.
Zhonghua Nei Ke Za Zhi|December 3, 2025
[The 515th case:dry mouth and dry eyes, parotid gland enlargement, pulmonary patchy shadows, muscular nodules]J Wang, X P Liu, Y Y Dong, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|June 9, 1999
Quantitative high-performance liquid chromatographic method for pharmacokinetic studies of the potent mast cell inhibitor 4-(4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline (WHI-P131)C L Chen, R Malaviya, H Chen, et al.
Pageof 11